Home Trials Genes Drugs 23andMe Graph Blog Contact

Home
Trials
Genes
Drugs
23andMe
Graph
Blog
Contact

Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

ClinicalTrials.gov
OpenTargets
ClinVar
PubChem

A Study of Minirin Melt in Patients With Nocturia

N/ACompletedNCT01212224

Ferring Pharmaceuticals2,187 enrolled

Overview

This is a confirmation of safety profile for Minirin Melt in clinical practice.

Study Type

OBSERVATIONAL

Enrollment

2,187

Conditions

Nocturia

Eligibility

Sex: ALLMin age: 18 YearsMax age: 64 Years

Medical Language ↔ Plain English

Inclusion Criteria: * nocturia Exclusion Criteria: * habitual or psychogenic polydipsia * known or suspected cardiac insufficiency and other conditions requiring treatment with diuretics * moderate and severe renal insufficiency * know hyponatremia * syndrome of inappropriate ADH secretion

Locations (81)

Outcomes

Primary Outcomes

Verify the safety profile

Time frame: 12 months

Secondary Outcomes

Safety aspect of dosage

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Nemocnice Rudolfa a Stefanie

Benešov, Czechia

Private ambulance Benešov

Benešov, Czechia

Private ambulance Beroun

Beroun, Czechia

Private ambulance - Slezská urologie, s.r.o.

Bohumín, Czechia

Health centre Brno

Brno, Czechia

Hospital Accident

Brno, Czechia

Hospital Delta - private ambulance

Brno, Czechia

Private ambulance Uro-Clinic, s.r.o.

Brno, Czechia

Urocentrum

Brno, Czechia

Private ambulance

Brno - Zábrdovice, Czechia

...and 71 more locations

NCT01212224 - A Study of Minirin Melt in Patients With Nocturia | Crick | Crick